Table 3. COX risk regression model analysis of factors affecting the survival of patients with GC.
| Variable | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | ||
| Age (>65/≤65) | 1.303 (0.934–1.817) | 0.119 | – | – | |
| Gender (male/female) | 1.086 (0.768–1.538) | 0.640 | – | – | |
| Grouping (diabetes/non-diabetes) | 1.926 (1.384–2.681) | 0.000 | 1.825 (1.276–2.610) | 0.001 | |
| Staging | 0.000 | 0.000 | |||
| I | 0.071 (0.034–0.148) | 0.000 | 0.093 (0.043–0.201) | 0.000 | |
| II | 0.107 (0.055–0.205) | 0.000 | 0.128 (0.065–0.253) | 0.000 | |
| III | 0.271 (0.185–0.395) | 0.000 | 0.313 (0.205–0.478) | 0.000 | |
| IV | – | – | |||
| Pathological type | 0.000 | 0.049 | |||
| Low differentiation | 0.293 (0.092–0.930) | 0.037 | 0.523 (0.151–1.809) | 0.306 | |
| Moderate differentiation | 0.125 (0.038–0.412) | 0.001 | 0.303 (0.083–1.109) | 0.071 | |
| High differentiation | 0.000 (0.000–4.75) | 0.959 | 0.000 (0.000–5.726) | 0.959 | |
| Squamous cell carcinoma | – | – | |||
| Treatment | 0.000 | 0.015 | |||
| Surgery + chemotherapy | 0.290 (0.182–0.462) | 0.000 | 0.429 (0.254–0.725) | 0.002 | |
| Surgery | 0.388 (0.217–0.695) | 0.001 | 0.515 (0.270–0.982) | 0.044 | |
| Chemotherapy | 0.521 (0.294–0.925) | 0.026 | 0.647 (0.348–1.201) | 0.167 | |
| Palliative care | – | ||||
| Comorbidity | 0.010 | 0.067 | |||
| Cardiovascular and cerebrovascular diseases | 0.492 (0.284–0.851) | 0.011 | 0.521 (0.285–0.955) | 0.035 | |
| Other chronic diseases | 0.735 (0.408–1.324) | 0.305 | 0.683 (0.350–1.332) | 0.263 | |
| No comorbidities | – | – | |||
GC, gastric cancer.